Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Citius Pharmaceuticals, Inc.

TRADE

NASDAQ: CTXRHealthcare / Biotechnology / -
1.62+0.02+1.25%Vol 68 0621Y Perf -43.84%
Oct 17th, 2018 15:48
BID1.41 ASK1.74
Open1.59 Previous Close1.60
Pre-Market- After-Trading-
 - -%  - -%
Target Price
10.50 
Analyst Rating
Strong Buy 1.00
Potencial %
548.15 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)26 
Earnings Rating
Price Range Ratio 52wk %
11.44 
Earnings Date

Today's Price Range

1.571.71

 

52wk Range

1.125.49

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
20.00%
3 Months
-38.40%
6 Months
-42.35%
1 Year
-43.84%
3 Years
-91.36%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
CTXR1.620.02001.25
AAPL221.19-0.9600-0.43
GOOG1 115.69-5.5900-0.50
MSFT110.71-0.2900-0.26
XOM81.500.30000.37
WFC54.460.73001.36
JNJ139.462.90002.12
FB159.420.64000.40
GE12.190.09000.74
JPM109.831.21001.11
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 1.30
Current Ratio 1.30
Long Term Debt to Total Capital -
Total Debt to Equity 0.01
Interest Coverage -15.00
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 1.09
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -1.90
Cash Flow Per Share -1.35
Price to Tangible Book36.47
Book Value per Share1.34
Enterprise Value (in ths.)21 061
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-87.41
ROE last 12 Months -76.64
Return on Assets (5Y Avg) -20.28
ROA last 12 Months -56.10
Return on Capital (5Y Avg) -
ROC last 12 Months -61.50
Return on invested Capital Q -8.87
Return on invested Capital Y-48.20
Assets Turnover0.00
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.140.00-
9/2018 FY-1.430.00-
12/2018 QR-0.220.00-
9/2019 FY-0.540.00-
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume68 062
Shares Outstanding (in ths.)16 200
Trades Count104
Dollar Volume103 265
Avg. Volume102 416
Avg. Weekly Volume61 222
Avg. Monthly Volume224 166
Avg. Quarterly Volume228 566

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

44%56%

Bearish Bullish

58%42%

Bearish Bullish

50%50%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x